Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Oxasaph-100 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Oxasaph-100

Approved

STANDARD

Oxasaph-100

Bruck Pharma Private Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: bddbf6745dcafe7c
Company: Bruck Pharma Private Limited
Type: Standard

Approval Details

Approval Id: bddbf6745dcafe7c
Drug Approval Philippines Name: Oxasaph-100
Product Name: Oxasaph-100
Registration Number: DRP-11224
Brand Name: Oxasaph-100
Generic Name: Oxaliplatin
Dosage Form: Lyophilized Powder for Injection (IV Infusion)
Dosage Strength: 100 mg
Manufacturer: Bruck Pharma Private Limited
Trader: Sapphire Lifesciences Pvt. Ltd.
Importer: Nelpa Lifesciences, Inc.
Distributor: Nelpa Lifesciences, Inc.
Issuance Date: 27 April 2023
Expiry Date: 15 February 2027
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

bddbf6745dcafe7c

Type

Standard

Back to Philippines FDA Approvals